Marta Cremonesi - Concepedia

Author

Marta Cremonesi

Also Known As

A. Canepa, A. Gilbert, Cremonesi, Marta, F. Chlebana, G. B. Cerati, G. Pruneri, G.B. Cerati, H. W. K. Cheung, H.W.K. Cheung, J.N. Butler

286

Publications

12.8K

Citations

H-Index

100

Concepts

All Affiliations

European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico Ripamonti University of Milan Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

About

Marta Cremonesi is an author at European Institute of Oncology specializing in medicine, nuclear medicine, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	37	4.2K
2	Health Sciences	22	28	1.5K
3	Engineering	13	15	1.5K
4	Biostatistics	4	4	218
5	Biomedical Engineering	1	1	212

Marta Cremonesi

102

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand, European Journal of Nuclear Medicine and Molecular Imaging	2013	790
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors Lisa Bodei, Mark Kidd, Giovanni Paganelli, European Journal of Nuclear Medicine and Molecular Imaging Neuroendocrine TumoursLong-term TolerabilityClinical FactorsEndocrine DiseaseMedicine	2014	451
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors Lisa Bodei, Marta Cremonesi, Mahila Ferrari, European Journal of Nuclear Medicine and Molecular Imaging UrologyRenal FunctionMedicineRadionuclide TherapyLong-term Evaluation	2008	413
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, European Journal of Nuclear Medicine and Molecular Imaging EngineeringMedicineRadionuclide TherapyTheranosticsNeuropeptide Receptor	2011	411
Observation of Higgs Boson Decay to Bottom Quarks A. M. Sirunyan, A. Tumasyan, W. Adam, Physical Review Letters	2018	331
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study Lisa Bodei, Marta Cremonesi, Stefania Zoboli, European Journal of Nuclear Medicine and Molecular Imaging Receptor-mediated Radionuclide TherapyEngineeringMedicineRadionuclide TherapyAmino Acid Infusion	2003	304
Safety of sentinel node biopsy in pregnant patients with breast cancer Oreste Gentilini, Marta Cremonesi, Giuseppe Trifirò, Annals of Oncology Breast OncologyMedicineGynecologySentinel Node BiopsyBreast Imaging	2004	229
Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin Giovanni Paganelli, Chiara Grana, Marco Chinol, European Journal of Nuclear Medicine and Molecular Imaging Neuro-oncologyEngineeringGliomaMedicineTheranostics	1999	212
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds Manuel Weber, Marnix G. E. H. Lam, Claudio Chiesa, European Journal of Nuclear Medicine and Molecular Imaging Primary Liver TumoursEanm Procedure GuidelineHepatologyRadiation TherapyHepatocellular Carcinoma	2022	207
Dosimetry in Peptide radionuclide receptor therapy: a review. Marta Cremonesi, Mahila Ferrari, Lisa Bodei, PubMed Radiation TherapyMedicineRadionuclide TherapyRadiopharmaceuticalsRadiopharmaceutical Therapy	2006	206

Page 1